These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31659493)

  • 41. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals.
    Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE
    J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
    Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE
    Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
    Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
    J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiosynthesis, radiochemical, and biological characterization of
    Akbar MU; Bokhari TH; Ahmad MR; Zia KM; Roohi S; Ayub N; Sohaib M
    J Cell Biochem; 2019 Sep; 120(9):14510-14517. PubMed ID: 30994957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new method for the radiochemical purity measurement of ¹¹¹In-pentetreotide.
    Salgado-Garcia C; Montoza-Aguado M; Luna-Alcaide AB; Segovia-Gonzalez MM; de Mora ES; Lopez-Martin J; Ramos-Font C; Jimenez-Heffernan A
    Nucl Med Commun; 2011 Dec; 32(12):1241-4. PubMed ID: 21946620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of a cost-effective alternative for a radiochromatography method to be used in a developing country.
    Ekoume FP; Boersma HH; Dong À Zok F; Rubow SM
    EJNMMI Radiopharm Chem; 2020 Apr; 5(1):9. PubMed ID: 32277373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system.
    Petrik M; Knetsch PA; Knopp R; Imperato G; Ocak M; von Guggenberg E; Haubner R; Silbernagl R; Decristoforo C
    Nucl Med Commun; 2011 Oct; 32(10):887-95. PubMed ID: 21876399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Umbricht CA; Benešová M; Schmid RM; Türler A; Schibli R; van der Meulen NP; Müller C
    EJNMMI Res; 2017 Dec; 7(1):9. PubMed ID: 28102507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Progress toward Microfluidic Quality Control Testing of Radiopharmaceuticals.
    Ha NS; Sadeghi S; van Dam RM
    Micromachines (Basel); 2017 Nov; 8(11):. PubMed ID: 30400527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.
    Wang J; Zang J; Wang H; Liu Q; Li F; Lin Y; Huo L; Jacobson O; Niu G; Fan X; Zhu Z; Chen X
    Clin Nucl Med; 2019 Jun; 44(6):431-438. PubMed ID: 30985422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of four alternative radiochemical purity testing methods for 99Tcm-sestamibi.
    Hung JC; Wilson ME; Gebhard MW; Gibbons RJ
    Nucl Med Commun; 1995 Feb; 16(2):99-104. PubMed ID: 7731625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of 99Tc on the radiochemical purity of 99mTc radiopharmaceuticals.
    Waight LA; Cunnane CM; O'Brien LM; Millar AM
    Nucl Med Commun; 2011 Aug; 32(8):752-6. PubMed ID: 21597394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.
    Umbricht CA; Benešová M; Schibli R; Müller C
    Mol Pharm; 2018 Jun; 15(6):2297-2306. PubMed ID: 29684274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of 99m Tc-MAG3: the effect on radiochemical purity of using sodium chloride injection from plastic ampoules that have been exposed to light.
    Beattie LA; O'Brien LM; Waight CC; Homer NZ; Andrew R; Millar AM
    Nucl Med Commun; 2008 Jul; 29(7):649-53. PubMed ID: 18528188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fully-automated synthesis of
    Eryilmaz K; Kilbas B
    EJNMMI Radiopharm Chem; 2021 Apr; 6(1):16. PubMed ID: 33864154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.
    Benešová M; Umbricht CA; Schibli R; Müller C
    Mol Pharm; 2018 Mar; 15(3):934-946. PubMed ID: 29400475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of alternative methods of preparing 99mTc-MAG3.
    Seetharaman S; Sosabowski MH; Ballinger JR
    Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rapid radiochemical purity testing method for 99mTc-tetrofosmin.
    Eggert LA; Dick MD; Mahoney DW; Olson JP; Werner GL; Hung JC
    J Nucl Med Technol; 2010 Jun; 38(2):81-4. PubMed ID: 20484182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of radiochemical purity control methods for 99Tcm radiopharmaceuticals used in hospital radiopharmacies.
    Mallol J; Bonino C
    Nucl Med Commun; 1997 May; 18(5):419-22. PubMed ID: 9194083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.